0.00Open0.00Pre Close0 Volume0 Open Interest20.00Strike Price0.00Turnover190.04%IV-33.78%PremiumMay 16, 2025Expiry Date5.05Intrinsic Value100Multiplier18DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6782Delta0.0562Gamma2.45Leverage Ratio-0.0608Theta-0.0071Rho-1.66Eff Leverage0.0121Vega
RxSight Stock Discussion
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$